kim newman, bsn, rn, cic baylor scott & white baylor ... · baylor scott & white –baylor...
TRANSCRIPT
Kim Newman, BSN, RN, CICBaylor Scott & White – Baylor University
Medical Center Dallas([email protected])
Kim Newman has nothing to disclose.
1. Learner will be able to identify challenges associated with high level disinfection of scopes.
2. Learner will be able to cite national standards and guidelines regarding high level disinfection of scopes.
3. Learner will be able to discuss how to perform an audit for compliance of practice.
Center for Disease Control (CDC)
Society for Gastroenterology Nurses & Assoc. (SGNA)
Association of Advancement of Medical Instrumentation (AAMI)
Association for Operating Room Nurses (AORN)
American Society for Gastrointestinal Endoscopy (ASGE)
American College of Gastroenterology (ACG)
Association for Professionals in Infection Control (APIC)
Endoscope reprocessing has a narrow margin of safety and any slight deviation from the recommended reprocessing protocol can lead to the survival of microorganisms and increased risk of infection.*
Number of steps is demanding & can easily lead to omission of 1 or more steps
Not adhering to evidence-based guidelines or manufacturer instructions for use (IFU)
Endoscope design itself poses a challenge
*Alfa M: Automated washing with the Reliance Endoscope Processing System and its equivalence to optimal manual cleaning, American Journal of Infection Control, 2006;34(9)561-570
1991 Gorse & Messner surveyed 2030 SGNA members◦ Compliance with existing guidelines ranged from
67% to 93%
1991 FDA & 3 State Health Dept. investigated 26 health care facilities◦ 24% of patient-ready endoscopes were culture
positive
2009 CDC piloted IPC tool of 68 ambulatory surgery centers◦ Adherence to guidelines uniform in 71.6%
Separate from patient procedural area
One-way workflow that separates contaminated area from clean area◦ Negative pressure between rooms
Handwashing sink separate from reprocessing sink
Eyewash stations if required
Education/Training/Competency Initially upon hire◦ Trained by Certified staff
Periodically according to policy When a new model of scope, reprocessing
equipment or chemical is introduced After updates to manufacturer’s IFUs Should always be followed by direct
observation of performance Certification does not mitigate need for
training and competency evaluation
IC 02.02.01 – reduce risk of infection due to medical equipment◦ 2016 74% of “immediate threat to life” findings
were related to HLD or sterilization issues
AHC – Ambulatory Health CenterCAH – Critical Access HospitalHAP – Joint Commission Accredited HospitalsOBS – Office Based Surgery Facility
Sterilization (critical items)◦ Process that destroys or eliminates all forms of
microbial life and is done by physical or chemical methods
High level disinfection (semi-critical items)◦ Process that eliminates many or all pathogenic
microorganisms, except bacterial spores
Cleaning (non-critical items)◦ Removing of visible soil
Follow manufacturer’s recommendations/IFUs
Pre-clean immediately after completion of procedure◦ Wiping exterior with enzymatic detergent
◦ Aspiration of large volume of detergent solution through air/water & biopsy channels
Missing air/water channel cleaning adapter (Olympus scopes)
Visible soil and tissue
Perform after each use and prior to manual cleaning◦ Detects damage to interior/exterior of scope
◦ Prevents damage due to fluid invasion
◦ Extends life of scope & prevents expensive repairs
Brushing and flushing channels and ports following manufacturer's IFUs
Complete within timeframe specified in manufacturer’s IFUs◦ If not done, follow manufacturer’s
recommendations on prolonged soaking time
Most critical step
Must use brushes appropriately sized ◦ Single use or thoroughly cleaned and disinfected
between uses
Consider the use of a rapid cleaning verification test◦ Quantitative tests (detect biological matter)
ATP
EndoCheck/Channel Check
◦ Qualitative tests (swabbing device, noting color change)
Verify® Resi-test™
*Recommended by AAMI, AORN, SGNA
Test Plan◦ Option 1 – monitor every
endoscope after use
◦ Option 2 – categorize by type/risk level
High Risk: duodenoscopes, EUS, ERCP, bronchoscopes
Not High Risk: colonoscopes, gastoscopes
Test Points◦ Instrument/suction channel
◦ Elevator mechanism
◦ Outer distal end
◦ Control Handle
◦ Instrument port
Endoscopy accessories (e.g., biopsy forceps) that come in contact with mucous membranes are classified as semi-critical and should be mechanically cleaned and receive at least high-level disinfection
Water bottles & connecting tube disinfection◦ Daily vs. between uses
Provides additional assurance that endoscope is clean and free of defects◦ Visually inspect for cracks, corrosion, discoloration,
retained debris
◦ Use magnification and adequate lighting
Automated endoscope reprocessors (AER)◦ Recommended when possible
◦ Approved connectors should be utilized
◦ Flush with alcohol and dry using forced filtered air
Liquid chemical disinfectants/sterilants(GUS® System)◦ Exposure time & temperature dependent upon
product used
Gas (EtO)
Run disinfection cycle per manufacturer’s IFUs
Preventive maintenance performed
Filter changes when required
Documentation
Drying the endoscope with medical grade air must be completed after every reprocessing cycle, both between patient procedures and before storage.◦ Moisture allows organisms to survive and multiply
◦ Promotes biofilm development
◦ Flush with 70% isopropyl alcohol followed by use of forced medical grade air
Store in manner that:◦ Prevents recontamination
◦ Protects equipment from damage
◦ Promotes drying
Hang vertically without coiling or
touching sides and bottom of cabinet
Ideally, scopes are not touching
each other
A few things to know
Dependent loops hold in moisture
If the bottom of cabinet has water spots-sign that scopes need longer air dry before storing
The bottom & sides of the cabinet must be clean, scope cannot touch the bottom
Scopes stored longer than hang time policy must be reprocessed prior to use
Shelf life between use◦ SGNA recommends reprocessing within 7 days
◦ APIC – no recommendation
◦ AORN – multi-disciplinary committee to perform risk assessment to determine
Essential for quality assurance & patient tracing if necessary
Policies should be developed by multidisciplinary team◦ Use
◦ Transport
◦ Reprocessing
◦ Storage
◦ Staff education/training/competency
◦ Ongoing quality assurance
Maintain a log to assist in an outbreak investigation if necessary:◦ Patient’s name and medical record number
◦ Date & procedure performed
◦ Serial number/identifier of endoscope
◦ Name of the person performing the cleaning & HLD/sterilization process
Repeat HLD
Culturing* and quarantine until negative
Liquid chemical sterilant processing system
Ethylene oxide (EtO) sterilization◦ EtO sterilization of flexible endoscopes is
infrequent because it requires a lengthy processing and aeration time (e.g., 12 hours) and is a potential hazard to staff and patients.
*Recommended by CDC, ASGE
Service according to manufacturer’s recommendations
Replacement interval is unknown◦ Dependent upon number of times used
Important to monitor scopes for damage & replace/repair per manufacturer’s recommendations
All essential steps of reprocessing are met and maintained
Endoscopes are cleaned at point of use & transported safely
Sufficient number of staff available Manufacturer’s IFUs are readily available & followed Necessary reprocessing equipment & supplies are
available Physical space is adequate HVAC parameters are maintained & monitored Storage of endoscopes is appropriate Documentation providing traceability is maintained Key Leadership involvement
Endoscopes – GI, OR
Bronchoscopes – GI, OR, Pulmonary, ICU
FEES Scopes – Speech therapy, NICU, Rehab
Cystoscopes – Urology unit/clinics, Lithotripsy
Laryngoscopes – ED, Head & Neck units/clinics, ICUs
TEE probes – Cardiopulmonary, OR
To date, nearly all published episodes of pathogen transmission related to GI endoscopy instruments have been associated with failure to follow established cleaning and disinfection/sterilization guidelines or use of defective equipment.
Complex design
Variety of manufacturers/models
Difficulty identifying damage
Inadequate training
Insufficient number of staff
Frequent disruptions during reprocessing
Limited accountability
Time pressures or demands for rapid turn-around.
Lack of certified individuals
Study Location Equipment Outcomes Organism Comments
Naas et al (2010) 9 and Carbonne et al (2010) 12
France Duodenoscope 3 infected10 colonized
Klebsiellapnueumoniae
The hospital changed to a glutaraldehyde decontamination bath followed by automated peracetic acid washer because of concern about Creutzfeldt-Jakob transmission; there may have been deficiencies in cleaning associated with the change in protocol
Koo et al (2012) 13
United Kingdom
Cystoscope 5 infected4 colonized
Klebsiellapneumoniae
Deficiencies noted in cleaning protocol of head of device; outbreak stopped with ETO sterilization
Alrabaa (2013) 14
United States
Duodenoscope 7 infected3 colonized
K. PneumoniaeEscherichia coli
Found to have a deficiency in mechanical removal of debris
Chang et al (2013) 15
China Ureteroscope 15 Enterobactercloacae
OPA sterilization alone failed to clear the device; required weekly ETO treatments
Epstein et al (2014) 11
United States
Duodenoscope 10 cases28colonized/100 screened
NDM-1 E coli HLD with OPA; outbreak terminated when changing to sterilization with ETO
Smith et al (2015) 16
United States
Duodenoscope 4 infected1 colonized
NDM-1 E coli Routine HLD; exact methodology not specified
Occurred even when manufacturer guidelines & professional guidelines followed correctly
Interim guidelines due to recent reports of CRE infections associated with endoscopy◦ Treatment options are typically limited & risk of
mortality is doubled
Since 1990, The FDA Safety Information & Adverse Event Reporting program (www.fda.gov/medwatch). ◦ Medical Device Reports submitted through
“Medwatch” can be reviewed on the FDA’s MAUDE (Manufacturer and User Facility Device Experience) database
Guideline for Disinfection and Sterilization in Healthcare Facilities 2008
◦ https://www.cdc.gov/hicpac/recommendations/flexible-endoscope-reprocessing.html
Naas T, Cuzon G, Babics A, Fortineau N, Boytchev I, Gayral F, et al. Endoscopyassociated transmission of carbapenem-resistant Klebsiella pneumonia producing KPC-2 beta-lactamase. J AntimicrobChemother 2010;65:1305-6
Carbonne A, Thiolet JM, Fournier S, Fortineau N, Kassis-Chikhani N, Boytchev I, et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 2010;15
Koo VS, O’Neill P, Elves A. Multidrug-resistant NDM-1 Klebsiella outbreak and infection control in endoscopic urology. BJU Int 2012;110:E922-6
Alrabaa S. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 2013;41:850
Chang CL, Su LH, Lu CM, Tai FT, Huang YC, Chang KK. Outbreak of ertapenemresistant Enterobactercloacae urinary tract infections due to a contaminated ureteroscope. J Hosp Infect 2013;85:118-24
Epstein L, Hunter JC, Arwady MA, Tsai V, Stein L, Gribogiannis M, et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014;312:1447-55
Smith ZL, Oh YS, Saeian K, Edmiston CE, Khan AH, Massey BT, et al. Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc 2015;81:1041-5
Thank you!